Possible acceleration of regression by antibiotic treatment in benign cephalic histiocytosis with infiltration of CD11a/CD11c+ macrophages

Acta Derm Venereol. 2010 Jul;90(4):429-30. doi: 10.2340/00015555-0872.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Biopsy
  • CD11a Antigen / analysis*
  • CD11c Antigen / analysis*
  • Histiocytosis, Non-Langerhans-Cell / immunology*
  • Histiocytosis, Non-Langerhans-Cell / pathology
  • Humans
  • Infant
  • Macrophages / drug effects*
  • Macrophages / immunology
  • Male
  • Remission Induction
  • Skin / drug effects*
  • Skin / immunology
  • Skin / microbiology
  • Skin / pathology
  • Staphylococcal Skin Infections / drug therapy*
  • Staphylococcal Skin Infections / immunology
  • Staphylococcal Skin Infections / microbiology
  • Staphylococcal Skin Infections / pathology
  • Staphylococcus aureus / isolation & purification
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • CD11a Antigen
  • CD11c Antigen